Differential splicing of exon 5 of the wilms tumour (WTI) gene

Genes Chromosomes and Cancer

Volumn 19, Issue 4, 1997, Pages 256-266

  Renshaw, Jane ^a   King Underwood, Linda ^a   Pritchard Jones, Kathryn ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; DNA BINDING; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROBLASTOMA; PRIORITY JOURNAL; RNA SPLICING; SIGNAL PROCESSING; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HUMANS; LEUKEMIA; LYMPHOID TISSUE; MALE; MICE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; RNA-DIRECTED DNA POLYMERASE; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED; UROGENITAL NEOPLASMS;

EID: 0030805513     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199708)19:4<256::AID-GCC8>3.0.CO;2-W     Document Type: Article

References (54)

1. Algar E, Khromykh T, Smith S, Blackburn D, Bryson G, Smith P (1996) A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005-1014.
2. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB (1993) The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40:85-97.
3. Bickmore WA, Oghene K, Little MH, Seawright A, van-Heyningen V, Hastie ND (1992) Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor WT1 gene transcript. Science 257:235-237.
4. Brown KW, Wilmore HP, Watson JE, Mott MG, Berry PJ, Maitland NJ (1993) Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosom Cancer 8:74-79.
5. Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J (1992) Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet 1:144-148.
6. Bruening W, Pelletier J (1995) A non-AUG translational initiation event generates novel WT1 isoforms. J Biol Chem 271:8646-8654.
7. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
8. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Coppes MJ, Ye Y, Rackley R, Zhao XL, Liefers GJ, Casey G, Williams BR (1993) Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res 53:2712-2714.
10. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher Fd (1992) Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 257:674-678.
11. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re G, Garvin A, Rosner M, Haber D (1995a) WT1 suppressed synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675.
12. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell RM, Isselbacher KJ, Haber DA (1995b) Truncated WT1 mutants alter the subnuclear localisation of the wild-type protein. Proc Natl Acad Sci USA 92:11960-11964.
13. Gessler M, Konig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, et al (1994) Infrequent mutation of the WT1 gene in 77 Wilms' Tumors. Hum Mutat 3:212-222.
14. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl Acad Sci USA 88:9618-9622.
15. Haber DA, Timmers HT, Pelletier J, Sharp PA, Housman DE (1992) A dominant mutation in the Wilms' tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci USA 89:6010-6014.
16. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ (1993) WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant. Science 262:2057-2059.
17. Haines DS, Landers JE, Engle LJ, George DL (1994) Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol Cell Biol 14:1171-1178.
18. Hewitt SM, Saunders GF (1996) Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function. Anticancer Res 16:621-626.
19. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071-3079.
20. Javier Lopez A (1995) Developmental role of transcription factor isoforms generated by alternative splicing. Dev Biol 172:396-411.
21. Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE, Niikawa N (1994) Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet 6:305-309.
22. Kennedy D, Ramsdale T, Mattick J, Little M (1996) An RNA recognition motif in Wilms tumour (WT1) protein revealed by structural modelling. Nature Genet 12:329-332.
23. Kent G, Coriat A, Sharpe P, Hastie N, Van Heyningen V (1995) The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene 11:1781-1792.
24. King-Underwood L, Renshaw J, Pritchard-Jones K (1996) Mutations in the Wilms' tumour gene WT1 in leukaemias. Blood 6:2171-2179.
25. Knudson A Jr, Strong LC (1972) Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313-324.
26. Kudoh T, Ishidate T, Moriyama M, Toyoshima K, Akiyama T (1995) G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc Natl Acad Sci USA 92:4517-4521.
27. Kudoh T, Ishidate T, Nakamura T, Toyoshima K, Akiyama T (1996) Constitutive expression of the Wilms tumour suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Oncogene 13:1431-1439.
28. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadesan M, Ross A, Cuzin F, van-Heyningen V, Hastie ND (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401.
29. Little MH, Prosser J, Condie A, Smith PJ, Van-Heyningen V, Hastie ND (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791-4795.
30. Little MH, Holmes G, Bickmore W, van Heyningen V, Hastie N, Wainwright B (1995) DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome point mutations. Hum Mol Genet 4:351-358.
31. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA (1995) The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 9:2143-2156.
32. Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJd, van der Eb AJ, Jochemsen AG (1996) Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene 12:537-546.
33. Moffett P, Bruening W, Nakagama H, Bardeesy N, Housman D, Housman DH, Pelletier J (1995) Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA 92:11105-11109.
34. Morris JF, Madden SL, Tournay OE, Conk DM, Sukhatme VP, Rauscher Fd (1991) Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6:2339-2348.
35. Nakagama H, Heinrich G, Pelletier J, Housman DE (1995) Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 15:1489-1498.
36. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher I, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA (1993) The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet 4:415-120.
37. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991a) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447.
38. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D (1991b) Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 5:1345-1356.
39. Phelan SA, Lindberg C, Call KM (1994) Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677-686.
40. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, Van Heyningen V, Hastie N (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-197.
41. Pritchard-Jones K, Renshaw J, King-Underwood L (1994) The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum Mol Genet 3:1633-1637.
42. Rauscher FD, Morris JF, Tournay OE, Cook DM, Curran T (1990) Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262.
43. Reddy J, Hosono S, Licht J (1995a) The transcriptional effect of WT1 is modulated by the choice of expression vector. J Biol Chem 270:29976-29982.
44. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, Licht JD (1995b) WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem 270:10878-10884.
45. Rupprecht HD, Drummond IA, Madden SL, Rauscher FR, Sukhatme VP (1994) The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206.
46. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A (1994) Downregulation of Wilms' tumor gene (WT1) during myclomonocytic differentiation in HL60 cells. Blood 83:1876-1882.
47. Sharma PM, Bowman M, Madden SL, Rauscher III FJ, Sukumar S (1994) RNA editing in the Wilms' tumour susceptibility gene, WT1. Gene Dev 8:720-731.
48. Sigalas I, Calvert AH, Anderson JJ, Neal DE, Lunec J (1996) Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer. Nature Med 2:912-917.
49. Simms L, Algar E, Smith P (1995) Splicing of exon 5 in the WT1 gene is disrupted in Wilms tumour. Eur J Cancer 31A:2270-2276.
50. Varanasi R, Bardeesy N, Ghahremani M, Petruzzi MJ, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91:3554-3558.
51. Walker C, Rutten F, Yuan X, Pass H, Mew DM, Everitt J (1994) Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 54:3101-3106.
52. Wang ZY, Madden SL, Deuel TF, Rauscher FD (1992) The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-20002.
53. Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF (1995) Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415-422.
54. Yamagami T, Sugiyama H, Inoue L, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T, Kishimoto T (1996) Growth inhibition of human leukaemic cells by WT1 antisense oligonucleotides: Implications for the involvement of WT1 in leukaemogenesis. Blood 87:2878-2884.